ARTICLE | Clinical News
Aerosolized form of an undisclosed osteoporosis drug: INHL began a Phase I study
June 3, 1996 7:00 AM UTC
Inhale Therapeutic Systems (INHL), Palo Alto, Calif. Product: Aerosolized form of an undisclosed osteoporosis drug Indication: Osteoporosis Status: INHL began a Phase I study of an undisclosed osteopo...